Cargando…
TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) accounts for approximately 10–15% of all breast cancer cases and is characterized by high invasiveness, high metastatic potential, relapse proneness, and poor prognosis. M2-like tumor-associated macrophages (TAMs) contribute to tumorigenesis and are promising tar...
Autores principales: | Lee, Chanju, Kim, Soyoung, Jeong, Chanmi, Cho, Inhee, Jo, Juyeon, Han, Ik-Hwan, Bae, Hyunsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874760/ https://www.ncbi.nlm.nih.gov/pubmed/35216272 http://dx.doi.org/10.3390/ijms23042157 |
Ejemplares similares
-
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
por: Kim, Soyoung, et al.
Publicado: (2022) -
Melittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophages
por: Jeong, Chanmi, et al.
Publicado: (2023) -
Combination of anti‐PD‐L1 antibody with peptide MEL‐dKLA targeting M2 tumor‐associated macrophages suppresses breast cancer metastasis
por: Lee, Chanju, et al.
Publicado: (2022) -
Therapeutic Effect of Melittin–dKLA Targeting Tumor-Associated Macrophages in Melanoma
por: Han, Ik-Hwan, et al.
Publicado: (2022) -
Melittin suppresses tumor progression by regulating tumor-associated macrophages in a Lewis lung carcinoma mouse model
por: Lee, Chanju, et al.
Publicado: (2017)